Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Non-cash Items (2019 - 2020)

Conmed (CNMD) has disclosed Non-cash Items for 2 consecutive years, with -$4.0 million as the latest value for Q4 2020.

  • For the quarter ending Q4 2020, Non-cash Items fell 115.4% year-over-year to -$4.0 million, compared with a TTM value of $55.0 million through Dec 2020, down 17.29%, and an annual FY2020 reading of $55.0 million, down 17.29% over the prior year.
  • Non-cash Items was -$4.0 million for Q4 2020 at Conmed, down from $28.3 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $32.9 million in Q2 2020 and bottomed at -$4.9 million in Q1 2019.